FDA.reportPublic FDA data

REXTOVY 4 MG in 0.25 ML Nasal Spray

RxCUI
2680741
RxNorm name
REXTOVY 4 MG in 0.25 ML Nasal Spray
Display name
REXTOVY 4 MG in 0.25 ML Nasal Spray
Full name
REXTOVY 4 MG in 0.25 ML Nasal Spray
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fe9735db-c57e-44a8-bffb-b87a84c2a6f3REXTOVY 4 MG in 0.25 ML Nasal Spray [PSN] · naloxone hydrochloride 16 MG/ML Nasal Spray [Rextovy] [SBD] · Rextovy 4 MG per 0.25 ML Nasal Spray [SY]38These highlights do not include all the information needed to use REXTOVY™ Nasal Spray safely and effectively. See full prescribing information for REXTOVY™ Nasal Spray. REXTOVY™ (naloxone hydrochloride) Nasal Spray Initial U.S. Approval: 197120240515